Medizinische Hochschule Hanover

Hanover, Lower Saxony 30625

0 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia (AML), Advanced Cancer, Biliary Tract Cancer, Chronic Myelomonocytic Leukemia (CMML), Chronic Spontaneous Urticaria, Crohn's Disease, Metastatic Cancer, Myelodysplastic Syndrome (MDS), Myeloproliferative Neoplasms (MPNs), Ulcerative Colitis

Studies at this site

• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations — Running, not enrolling
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria — Stopped early